BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 21930830)

  • 1. Management of anemia in cancer patients: transfusions.
    Schrijvers D
    Oncologist; 2011; 16 Suppl 3():12-8. PubMed ID: 21930830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of blood transfusions and preoperative anemia on long-term survival in patients operated for non-small cell lung cancer.
    Panagopoulos ND; Karakantza M; Koletsis E; Apostolakis E; Sakellaropoulos GC; Filos KS; Eleni T; Dougenis D
    Lung Cancer; 2008 Nov; 62(2):273-80. PubMed ID: 18430486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Practice and costs of red blood cell (RBC) transfusion in an oncological unit.
    Norum J; Moen MA
    Anticancer Res; 2008; 28(1B):459-64. PubMed ID: 18383885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient blood transfusion management: discharge hemoglobin level as a surrogate marker for red blood cell utilization appropriateness.
    Edwards J; Morrison C; Mohiuddin M; Tchatalbachev V; Patel C; Schwickerath VL; Menitove JE; Singh G
    Transfusion; 2012 Nov; 52(11):2445-51. PubMed ID: 22413968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Costs associated with blood transfusions in Sweden--the societal cost of autologous, allogeneic and perioperative RBC transfusion.
    Glenngård AH; Persson U; Söderman C
    Transfus Med; 2005 Aug; 15(4):295-306. PubMed ID: 16101807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood management in intensive care medicine: CRIT and ABC--what can we learn?
    Spahn DR; Marcucci C
    Crit Care; 2004 Apr; 8(2):89-90. PubMed ID: 15025763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Five drivers shifting the paradigm from product-focused transfusion practice to patient blood management.
    Hofmann A; Farmer S; Shander A
    Oncologist; 2011; 16 Suppl 3():3-11. PubMed ID: 21930829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant human erythropoietin in the treatment of cancer-related or chemotherapy-induced anaemia in patients with solid tumours.
    Nowrousian MR
    Med Oncol; 1998 Aug; 15 Suppl 1():S19-28. PubMed ID: 9785333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risks, benefits, alternatives and indications of allogenic blood transfusions.
    Madjdpour C; Heindl V; Spahn DR
    Minerva Anestesiol; 2006 May; 72(5):283-98. PubMed ID: 16675937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RBC transfusions among hemodialysis patients (1999-2010): influence of hemoglobin concentrations below 10 g/dL.
    Gilbertson DT; Monda KL; Bradbury BD; Collins AJ
    Am J Kidney Dis; 2013 Nov; 62(5):919-28. PubMed ID: 23815986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anemia and perioperative red blood cell transfusion: a matter of tolerance.
    Madjdpour C; Spahn DR; Weiskopf RB
    Crit Care Med; 2006 May; 34(5 Suppl):S102-8. PubMed ID: 16617252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical, quality of life, and economic consequences of chronic anemia and transfusion support in patients with myelodysplastic syndromes.
    Platzbecker U; Hofbauer LC; Ehninger G; Hölig K
    Leuk Res; 2012 May; 36(5):525-36. PubMed ID: 22300879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Red blood cell transfusions and iron overload in the treatment of patients with myelodysplastic syndromes.
    Jabbour E; Kantarjian HM; Koller C; Taher A
    Cancer; 2008 Mar; 112(5):1089-95. PubMed ID: 18186499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients previously transfused or treated with epoetin alfa at low baseline hemoglobin are at higher risk for subsequent transfusion: an integrated analysis of the Canadian experience.
    Quirt I; Kovacs M; Couture F; Turner AR; Noble M; Burkes R; Dolan S; Plante RK; Lau CY; Chang J
    Oncologist; 2006 Jan; 11(1):73-82. PubMed ID: 16401716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: a randomized, double-blind, placebo-controlled trial.
    Silver M; Corwin MJ; Bazan A; Gettinger A; Enny C; Corwin HL
    Crit Care Med; 2006 Sep; 34(9):2310-6. PubMed ID: 16878035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A retrospective review of blood transfusions in cancer patients with anemia.
    Estrin JT; Schocket L; Kregenow R; Henry DH
    Oncologist; 1999; 4(4):318-24. PubMed ID: 10476543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anemia management program reduces transfusion volumes, incidence of ventilator-associated pneumonia, and cost in trauma patients.
    Earley AS; Gracias VH; Haut E; Sicoutris CP; Wiebe DJ; Reilly PM; Schwab CW
    J Trauma; 2006 Jul; 61(1):1-5; discussion 5-7. PubMed ID: 16832243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant human erythropoietin beta therapy: an effective strategy to reduce transfusion requirement in children receiving anticancer treatment.
    Corapcioglu F; Aksu G; Basar EZ; Demirel A; Oncel S; Mutlu A
    Pediatr Hematol Oncol; 2008 Sep; 25(6):509-21. PubMed ID: 18728970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of risk factors for requiring transfusion during front-line chemotherapy for ovarian cancer.
    Hensley ML; Lebeau D; Leon LF; Venkatraman E; Waltzman R; Sabbatini P; Almadrones L; Chi D; Spriggs D
    Gynecol Oncol; 2001 Jun; 81(3):485-9. PubMed ID: 11371143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Transfusion of recuperated blood in total knee arthroplasty].
    Pitsaer E
    Rev Chir Orthop Reparatrice Appar Mot; 2002 Dec; 88(8):777-89. PubMed ID: 12503019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.